For patients who were unable to take medications by mouth, lopinavir–ritonavir (at the same dose) was administered as a 5-ml suspension every 12 hours through a nasogastric tube. Patients in the ...

Lopinavir is a newly developed inhibitor of human immunodeficiency virus (HIV) protease that, when formulated with ritonavir, yields mean trough plasma lopinavir concentrations that are at least ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window An open-label trial found no benefit for lopinavir-ritonavir (Kaletra), a protease inhibitor used primarily in HIV ...

Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations. Antimicrobial Agents and Chemotherapy , 2020; DOI: 10.1128/AAC.01177-20 Cite This ...

Lopinavir and hydroxychloroquine do not reach sufficient concentrations in the lungs, to inhibit the virus replication. Until recently, both drugs were regarded as potential agents in the fight ...

The analysis focused on patients who initiated treatment with ritonavir combined with lopinavir (n=6,668) or atazanavir (n=4,301). Primary outcomes were all-cause mortality and clinical AIDS ...

Review the side-effects of Lopinavir and Ritonavir as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication.

Lopinavir is a drug against HIV, hydroxychloroquine is used to treat malaria and rheumatism. Until recently, both drugs were regarded as potential agents in the fight against the coronavirus ...

Lopinavir is a drug against HIV; hydroxychloroquine is used to treat malaria and rheumatism. Until recently, both drugs were regarded as potential agents in the fight against the coronavirus SARS ...